"disease modifying nutricals" for multiple sclerosis

Pharmacology and Therapeutics

Volumn 148, Issue , 2015, Pages 85-113

  Schmitz, Katja ^a   Barthelmes, Julia ^a   Stolz, Leonie ^a   Beyer, Susanne ^a   Diehl, Olaf ^a   Tegeder, Irmgard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Dietary supplements; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Nutricals; Therapeutics

Indexed keywords

APOLIPOPROTEIN E; ASCORBIC ACID; BOWMAN BIRK INHIBITOR; CANNABIDIOL; CANNABINOID RECEPTOR; COUMESTROL; CYANOCOBALAMIN; DAIDZEIN; ENDOCANNABINOID; GENISTEIN; GLUTEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; METALLOPROTEINASE; MINERAL; PHYTOESTROGEN; POLYUNSATURATED FATTY ACID; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROBIOTIC AGENT; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; RETINOL; STAT PROTEIN; TOLL LIKE RECEPTOR; TRACE ELEMENT; TWIK RELATED POTASSIUM CHANNEL 1; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; BIOLOGICAL PRODUCT; LIPID;

ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; DIET SUPPLEMENTATION; ENZYME INHIBITION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; IMMUNOCOMPETENT CELL; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SOYBEAN; T LYMPHOCYTE; TRICHURIS SUIS; ANIMAL;

ANIMALS; BIOLOGICAL PRODUCTS; DIETARY SUPPLEMENTS; HUMANS; LIPIDS; MULTIPLE SCLEROSIS;

EID: 84923287290     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.11.015     Document Type: Review

References (366)

1. N.J. Aburto, A. Ziolkovska, L. Hooper, P. Elliott, F.P. Cappuccio, and J.J. Meerpohl Effect of lower sodium intake on health: systematic review and meta-analyses BMJ 346 2013 1326
2. L. Adorini, and G. Penna Control of autoimmune diseases by the vitamin D endocrine system Nat Clin Pract Rheumatol 4 2008 404 412
3. O. Aktas, T. Prozorovski, A. Smorodchenko, N.E. Savaskan, R. Lauster, and P.M. Kloetzel Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis J Immunol 173 2004 5794 5800
4. H. Almukadi, H. Wu, M. Bohlke, C.J. Kelley, T.J. Maher, and A. Pino-Figueroa The macamide N-3-methoxybenzyl-linoleamide is a time-dependent fatty acid amide hydrolase (FAAH) inhibitor Mol Neurobiol 48 2013 333 339
5. A. Alonso, and M.A. Hernán Temporal trends in the incidence of multiple sclerosis: a systematic review Neurology 71 2008 129 135
6. R. Anangi, S. Koshy, R. Huq, C. Beeton, W.J. Chuang, and G.F. King Recombinant expression of margatoxin and agitoxin-2 in Pichia pastoris: an efficient method for production of KV1.3 channel blockers PLoS One 7 2012 e52965
7. E.J. Anderson, K.A. Thayne, M. Harris, S.R. Shaikh, T.M. Darden, and D.S. Lark Do fish oil omega-3 fatty acids enhance antioxidant capacity and mitochondrial fatty acid oxidation in human atrial myocardium via PPARgamma activation? Antioxid Redox Signal 21 2014 1156 1163
8. A. Ariel, P.L. Li, W. Wang, W.X. Tang, G. Fredman, and S. Hong The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering J Biol Chem 280 2005 43079 43086
9. K. Asano, S. Yoshimura, and A. Nakane Alteration of intestinal microbiota in mice orally administered with salmon cartilage proteoglycan, a prophylactic agent PLoS One 8 2013 e75008
10. A. Ascherio, and K.L. Munger Environmental risk factors for multiple sclerosis. Part I: the role of infection Ann Neurol 61 2007 288 299
11. A. Ascherio, K.L. Munger, R. White, K. Kochert, K.C. Simon, and C.H. Polman Vitamin D as an early predictor of multiple sclerosis activity and progression JAMA Neurol 71 2014 306 314
12. C. Avolio, M. Filippi, C. Tortorella, M.A. Rocca, M. Ruggieri, and F. Agosta Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment Mult Scler 11 2005 441 446
13. A.H. Badawi, P. Kiptoo, W.T. Wang, I.Y. Choi, P. Lee, and C.M. Vines Suppression of EAE and prevention of blood-brain barrier breakdown after vaccination with novel bifunctional peptide inhibitor Neuropharmacology 62 2012 1874 1881
14. V. Badmaev, P.B. Kozlowski, G.B. Schuller-Levis, and H.M. Wisniewski The therapeutic effect of an herbal formula Badmaev 28 (padma 28) on experimental allergic encephalomyelitis (EAE) in SJL/J mice Phytother Res 13 1999 218 221
15. D. Baitsch, H.H. Bock, T. Engel, R. Telgmann, C. Muller-Tidow, and G. Varga Apolipoprotein E induces antiinflammatory phenotype in macrophages Arterioscler Thromb Vasc Biol 31 2011 1160 1168
16. D. Baker, and S. Amor Multiple sclerosis - from bench to bedside CNS Neurol Disord Drug Targets 11 2012 495 496
17. D. Baker, G. Pryce, W.L. Davies, and C.R. Hiley In silico patent searching reveals a new cannabinoid receptor Trends Pharmacol Sci 27 2006 1 4
18. M.P. Barnes Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain Expert Opin Pharmacother 7 2006 607 615
19. P.J. Barnes Receptor heterodimerization: a new level of cross-talk J Clin Invest 116 2006 1210 1212
20. P.J. Barnes, and M. Karin Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 1997 1066 1071
21. D. Bates, N.E. Cartlidge, J.M. French, M.J. Jackson, S. Nightingale, and D.A. Shaw A double-blind controlled trial of long chain n - 3 polyunsaturated fatty acids in the treatment of multiple sclerosis J Neurol Neurosurg Psychiatry 52 1989 18 22
22. D. Bates, P.R. Fawcett, D.A. Shaw, and D. Weightman Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis Br Med J 2 1977 932 933
23. D. Bates, P.R. Fawcett, D.A. Shaw, and D. Weightman Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis Br Med J 2 1978 1390 1391
24. M.C. Bateson, D. Hopwood, and J.B. MacGillivray Jejunal morphology in multiple sclerosis Lancet 1 1979 1108 1110
25. H.A. Bawadi, T.M. Antunes, F. Shih, and J.N. Losso In vitro inhibition of the activation of Pro-matrix Metalloproteinase 1 (Pro-MMP-1) and Pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman-Birk inhibitors J Agric Food Chem 52 2004 4730 4736
26. D. Becker, N. Zahn, T. Deller, and A. Vlachos Tumor necrosis factor alpha maintains denervation-induced homeostatic synaptic plasticity of mouse dentate granule cells Front Cell Neurosci 7 2013 257
27. + channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation J Immunol 166 2001 936 944
28. + channels and inhibits T lymphocyte proliferation J Biol Chem 283 2008 988 997
29. + channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis Proc Natl Acad Sci U S A 98 2001 13942 13947
30. F. Benzel, H. Erdur, S. Kohler, M. Frentsch, A. Thiel, and L. Harms Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients J Helminthol 86 2012 339 347
31. C.T. Bever Jr., D. Young, P.A. Anderson, A. Krumholz, K. Conway, and J. Leslie The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial Neurology 44 1994 1054 1059
32. G.-P. Bezerra, R.W.D.S. Góis, T.S. de Brito, F.J.B. de Lima, M.A.M. Bandeira, and N.R. Romero Phytochemical study guided by the myorelaxant activity of the crude extract, fractions and constituent from stem bark of Hymenaea courbaril L. J Ethnopharmacol 149 2013 62 69
33. A.L. Bhakar, L.L. Tannis, C. Zeindler, M.P. Russo, C. Jobin, and D.S. Park Constitutive nuclear factor-kappa B activity is required for central neuron survival J Neurosci 22 2002 8466 8475
34. T. Bisogno Endogenous cannabinoids: structure and metabolism J Neuroendocrinol 20 Suppl. 1 2008 1 9
35. S. Bittner, M.A. Bauer, P. Ehling, N. Bobak, J. Breuer, and A.M. Herrmann The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis Exp Neurol 238 2012 149 155
36. S. Bittner, S.G. Meuth, K. Gobel, N. Melzer, A.M. Herrmann, and O.J. Simon TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system Brain 132 2009 2501 2516
37. S. Bittner, T. Ruck, M.K. Schuhmann, A.M. Herrmann, H. Moha ou Maati, and N. Bobak Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS Nat Med 19 2013 1161 1165
38. B. Blanchard, T. Heurtaux, C. Garcia, N.M. Moll, C. Caillava, and L. Grandbarbe Tocopherol derivative TFA-12 promotes myelin repair in experimental models of multiple sclerosis J Neurosci 33 2013 11633 11642
39. J.L. Blankman, G.M. Simon, and B.F. Cravatt A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol Chem Biol 14 2007 1347 1356
40. V. Bockhart, C.E. Constantin, A. Haussler, N. Wijnvoord, M. Kanngiesser, and T. Myrczek Inhibitor kappaB Kinase beta deficiency in primary nociceptive neurons increases TRP channel sensitivity J Neurosci 29 2009 12919 12929
41. V. Brinkmann, A. Billich, T. Baumruker, P. Heining, R. Schmouder, and G. Francis Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat Rev Drug Discov 9 2010 883 897
42. B. Brochet, P. Guinot, J.M. Orgogozo, C. Confavreux, L. Rumbach, and V. Lavergne Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis J Neurol Neurosurg Psychiatry 58 1995 360 362
43. J.M. Burton, S. Kimball, R. Vieth, A. Bar-Or, H.M. Dosch, and R. Cheung A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis Neurology 74 2010 1852 1859
44. A.M. Butt, and A. Kalsi Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions J Cell Mol Med 10 2006 33 44
45. A. Cabranes, K. Venderova, E. de Lago, F. Fezza, A. Sanchez, and L. Mestre Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis Neurobiol Dis 20 2005 207 217
46. A. Cabrelle, I. Dell'Aica, L. Melchiori, S. Carraro, E. Brunetta, and R. Niero Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease J Leukoc Biol 83 2008 212 219
47. A. Cadaveira-Mosquera, S.J. Ribeiro, A. Reboreda, M. Perez, and J.A. Lamas Activation of TREK currents by the neuroprotective agent riluzole in mouse sympathetic neurons J Neurosci 31 2011 1375 1385
48. M.D. Cahalan, and K.G. Chandy Ion channels in the immune system as targets for immunosuppression Curr Opin Biotechnol 8 1997 749 756
49. G. Calviello, H.-M. Su, K.H. Weylandt, E. Fasano, S. Serini, and A. Cittadini Experimental evidence of omega-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases Biomed Res Int 2013 2013 743171
50. M.T. Cantorna, C.E. Hayes, and H.F. DeLuca 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis Proc Natl Acad Sci U S A 93 1996 7861 7864
51. M.T. Cantorna, J. Humpal-Winter, and H.F. DeLuca Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice J Nutr 129 1999 1966 1971
52. D. Centonze, M. Bari, S. Rossi, C. Prosperetti, R. Furlan, and F. Fezza The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis Brain 130 2007 2543 2553
53. N.L. Chanaday, A.F. Bem, and G.A. Roth Effect of diphenyl diselenide on the development of experimental autoimmune encephalomyelitis Neurochem Int 59 2011 1155 1162
54. J.H. Chang, H.R. Cha, D.S. Lee, K.Y. Seo, and M.-H. Kweon 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis PLoS One 5 2010 e12925
55. S.S. Chatterjee, S.K. Bhattacharya, M. Wonnemann, A. Singer, and W.E. Muller Hyperforin as a possible antidepressant component of hypericum extracts Life Sci 63 1998 499 510
56. W. Chearwae, and J.J. Bright 15-Deoxy-delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte J Clin Immunol 28 2008 558 570
57. C.C. Chen, T.H. Hung, Y.H. Wang, C.W. Lin, P.Y. Wang, and C.Y. Lee Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-kappaB signaling after experimental traumatic brain injury PLoS One 7 2012 e30294
58. T.-J. Chen, J.-Y. Jeng, C.-W. Lin, C.-Y. Wu, and Y.-C. Chen Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells Toxicology 223 2006 113 126
59. Z. Chen, and T.D. Palmer Differential roles of TNFR1 and TNFR2 signaling in adult hippocampal neurogenesis Brain Behav Immun 30 2013 45 53
60. C.J. Chen, S.-L. Raung, S.-L. Liao, and S.-Y. Chen Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia Biochem Pharmacol 67 2004 957 965
61. K.C. Choi, M.G. Jung, Y.H. Lee, J.C. Yoon, S.H. Kwon, and H.B. Kang Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation Cancer Res 69 2009 583 592
62. A.W. Clark, C.A. Krekoski, S.S. Bou, K.R. Chapman, and D.R. Edwards Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia Neurosci Lett 238 1997 53 56
63. + channels Ann N Y Acad Sci 868 1999 233 285
64. C. Collin, P. Davies, I.K. Mutiboko, and S. Ratcliffe Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis Eur J Neurol 14 2007 290 296
65. A. Compston, and A. Coles Multiple sclerosis Lancet 372 2008 1502 1517
66. J. Correale, and M. Farez Association between parasite infection and immune responses in multiple sclerosis Ann Neurol 61 2007 97 108
67. J. Correale, and M.F. Farez Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients? Front Cell Infect Microbiol 2 2012 112
68. J. Correale, and A. Villa The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting Autoimmunity 40 2007 148 160
69. + channels characterized from Androctonus mauretanicus mauretanicus venom J Biol Chem 267 1992 1640 1647
70. J.E. Croy, T. Brandon, and E.A. Komives Two apolipoprotein E mimetic peptides, ApoE(130-149) and ApoE(141-155)2, bind to LRP1 Biochemistry 43 2004 7328 7335
71. H. Dai, B. Ciric, G.X. Zhang, and A. Rostami Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS Immunol Res 51 2011 145 152
72. U.N. Das Is there a role for saturated and long-chain fatty acids in multiple sclerosis? Nutrition 19 2003 163 166
73. S. Dasgupta, A. Roy, M. Jana, D.M. Hartley, and K. Pahan Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-alpha Mol Pharmacol 72 2007 934 946
74. M.L. De Paula, D.H. Rodrigues, H.C. Teixeira, M.M. Barsante, M.A. Souza, and A.P. Ferreira Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis Int Immunopharmacol 8 2008 1291 1297
75. R. Di Marco, K. Mangano, C. Quattrocchi, F. Amato, F. Nicoletti, and K. Buschard Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet APMIS 112 2004 651 655
76. A. Diab, R.Z. Hussain, A.E. Lovett-Racke, J.A. Chavis, P.D. Drew, and M.K. Racke Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis J Neuroimmunol 148 2004 116 126
77. M. Dona, I. Dell'Aica, E. Pezzato, L. Sartor, F. Calabrese, and M. Della Barbera Hyperforin inhibits cancer invasion and metastasis Cancer Res 64 2004 6225 6232
78. S.E. Dunn, R. Bhat, D.S. Straus, R.A. Sobel, R. Axtell, and A. Johnson Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity J Exp Med 207 2010 1599 1608
79. J. Dunn, and A. Blight Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis Curr Med Res Opin 27 2011 1415 1423
80. + T helper cell differentiation and inflammatory diseases Cytokine 47 2009 149 156
81. M. Emmanouil, E. Taoufik, V. Tseveleki, S.S. Vamvakas, T. Tselios, and M. Karin Neuronal IkappaB kinase beta protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system J Immunol 183 2009 7877 7889
82. S. Endres, R. Ghorbani, V.E. Kelley, K. Georgilis, G. Lonnemann, and J.W. van der Meer The effect of dietary supplementation with n - 3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells N Engl J Med 320 1989 265 271
83. M.P. Endsley, N. Aggarwal, M.A. Isbell, C.E. Wheelock, B.D. Hammock, and J.R. Falck Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: location, hydrolysis and 12-lipoxygenase metabolism Int J Cancer 121 2007 984 991
84. B. Engelhardt Molecular mechanisms involved in T cell migration across the blood-brain barrier J Neural Transm 113 2006 477 485
85. T. Esatbeyoglu, P. Huebbe, I.M.A. Ernst, D. Chin, A.E. Wagner, and G. Rimbach Curcumin - from molecule to biological function Angew Chem Int Ed Engl 51 2012 5308 5332
86. C. Espejo, and X. Montalban Dalfampridine in multiple sclerosis: from symptomatic treatment to immunomodulation Clin Immunol 142 2012 84 92
87. C.M. Fanger, S. Ghanshani, N.J. Logsdon, H. Rauer, K. Kalman, and J. Zhou Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1 J Biol Chem 274 1999 5746 5754
88. + tolerogenic DCs and enhances Treg, reducing the severity of EAE CNS Neurosci Ther 19 2013 269 377
89. J.O. Fleming, A. Isaak, J.E. Lee, C.C. Luzzio, M.D. Carrithers, and T.D. Cook Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study Mult Scler 17 2011 743 754
90. Z. Fonseca-Kelly, M. Nassrallah, J. Uribe, R.S. Khan, K. Dine, and M. Dutt Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis Front Neurol 3 2012 84
91. M.A. Friese, B. Schattling, and L. Fugger Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis Nat Rev Neurol 10 2014 225 238
92. E.M. Frohman, M.K. Racke, and C.S. Raine Multiple sclerosis - the plaque and its pathogenesis N Engl J Med 354 2006 942 955
93. E. Furrie Probiotics and allergy Proc Nutr Soc 64 2005 465 469
94. M. Gambuzza, N. Licata, E. Palella, D. Celi, V. Foti Cuzzola, and D. Italiano Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management J Neuroimmunol 239 2011 1 12
95. G.-T. Gang, J.H. Hwang, Y.-H. Kim, J.-R. Noh, K.-S. Kim, and J.Y. Jeong Protection of NAD(P)H:quinone oxidoreductase 1 against renal ischemia/reperfusion injury in mice Free Radic Biol Med 67 2014 139 149
96. I. Gantz, A. Muraoka, Y.K. Yang, L.C. Samuelson, E.M. Zimmerman, and H. Cook Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis Genomics 42 1997 462 466
97. E. Garcion, N. Wion-Barbot, C.N. Montero-Menei, F. Berger, and D. Wion New clues about vitamin D functions in the nervous system Trends Endocrinol Metab 13 2002 100 105
98. K. Gasiorowski, E. Lamer-Zarawska, J. Leszek, K. Parvathaneni, B.B. Yendluri, and Z. Blach-Olszewska Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration? CNS Neurol Disord Drug Targets 10 2011 184 191
99. J. Geisel, J. Bruck, I. Glocova, K. Dengler, T. Sinnberg, and O. Rothfuss Sulforaphane protects from T cell-mediated autoimmune disease by inhibition of IL-23 and IL-12 in dendritic cells J Immunol 192 2014 3530 3539
100. S. Giacoppo, M. Galuppo, R. Iori, G.R. De Nicola, G. Cassata, and P. Bramanti Protective role of (RS)-glucoraphanin bioactivated with myrosinase in an experimental model of multiple sclerosis CNS Neurosci Ther 19 2013 577 584
101. Y. Gilgun-Sherki, E. Melamed, and D. Offen The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy J Neurol 251 2004 261 268
102. K. Gobel, J.H. Wedell, A.M. Herrmann, L. Wachsmuth, S. Pankratz, and S. Bittner 4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis Exp Neurol 248 2013 62 71
103. S.M. Gold, M.V. Sasidhar, L.B. Morales, S. Du, N.L. Sicotte, and S.K. Tiwari-Woodruff Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha) Lab Invest 89 2009 1076 1083
104. P. Goldberg, M.C. Fleming, and E.H. Picard Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D Med Hypotheses 21 1986 193 200
105. R.E. Gonsette Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity J Neurol Sci 274 2008 48 53
106. D.S. Goodin, E.M. Frohman, G.P. Garmany, J. Halper, W.H. Likosky, and F.D. Lublin Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines Neurology 58 2002 169 178
107. A.D. Goodman, T.R. Brown, K.R. Edwards, L.B. Krupp, R.T. Schapiro, and R. Cohen A phase 3 trial of extended release oral dalfampridine in multiple sclerosis Ann Neurol 68 2010 494 502
108. B. Gran, N. Tabibzadeh, A. Martin, E.S. Ventura, J.H. Ware, and G.X. Zhang The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis Mult Scler 12 2006 688 697
109. N. Graudal, G. Jurgens, B. Baslund, and M.H. Alderman Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis Am J Hypertens 9 2014 1129 1137
110. L. Grimaldi, F. Barkhof, M. Beelke, J. Burton, T. Holmoy, and R. Hupperts A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis Neurology 78 2012 841
111. G.A. Gualdoni, J.J. Kovarik, J. Hofer, F. Dose, M. Pignitter, and D. Doberer Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation Biochim Biophys Acta 1840 2014 95 105
112. X. Guo, C. Harada, K. Namekata, A. Matsuzawa, M. Camps, and H. Ji Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway EMBO Mol Med 2 2010 504 515
113. R. Guo, B. Liu, K. Wang, S. Zhou, W. Li, and Y. Xu Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-kappaB pathway Diab Vasc Dis Res 11 2014 92 102
114. M. Hadjivassiliou, A. Gibson, G.A. Davies-Jones, A.J. Lobo, T.J. Stephenson, and A. Milford-Ward Does cryptic gluten sensitivity play a part in neurological illness? Lancet 347 1996 369 371
115. L. Haider, M.T. Fischer, J.M. Frischer, J. Bauer, R. Hoftberger, and G. Botond Oxidative damage in multiple sclerosis lesions Brain 134 2011 1914 1924
116. L.S. Harbige, and M.K. Sharief Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis Br J Nutr 98 Suppl. 1 2007 S46 S53
117. B.T. Hawkins, and T.P. Davis The blood-brain barrier/neurovascular unit in health and disease Pharmacol Rev 57 2005 173 185
118. C.E. Hayes, F.E. Nashold, K.M. Spach, and L.B. Pedersen The immunological functions of the vitamin D endocrine system Cell Mol Biol 49 2003 277 300
119. Y. He, M. Du, Y. Gao, H. Liu, H. Wang, and X. Wu Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels PLoS One 8 2013 e76495
120. F.J. He, J. Li, and G.A. Macgregor Effect of longer-term modest salt reduction on blood pressure Cochrane Database Syst Rev 4 2013 CD004937
121. D. Heber, Z. Li, M. Garcia-Lloret, A.M. Wong, T.Y. Lee, and G. Thames Sulforaphane-rich broccoli sprout extract attenuates nasal allergic response to diesel exhaust particles Food Funct 5 2014 35 41
122. K. Herges, J.M. Millward, N. Hentschel, C. Infante-Duarte, O. Aktas, and F. Zipp Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation PLoS One 6 2011 e25456
123. + channel involved in neuroprotection and general anesthesia EMBO J 23 2004 2684 2695
124. D.C. Hewson Is there a role for gluten-free diets in multiple sclerosis? Hum Nutr Appl Nutr 38 1984 417 420
125. H. Hibino, A. Inanobe, K. Furutani, S. Murakami, I. Findlay, and Y. Kurachi Inwardly rectifying potassium channels: their structure, function, and physiological roles Physiol Rev 90 2010 291 366
126. M.F. Holick Vitamin D deficiency N Engl J Med 357 2007 266 281
127. E. Honore The neuronal background K2P channels: focus on TREK1 Nat Rev Neurosci 8 2007 251 261
128. + T lymphocytes J Immunol 179 2007 4563 4570
129. 2+ levels in MDCK renal tubular cells Life Sci 68 2001 997 1004
130. C.J. Huang, R. Nazarian, J. Lee, P.M. Zhao, A. Espinosa-Jeffrey, and J. de Vellis Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line Int J Dev Neurosci 20 2002 289 296
131. A.L. Hunter, B.W. Rees, and L.T. Jones Gluten antibodies in patients with multiple sclerosis Ann N Y Acad Sci 38 1984 142 143
132. M. Hutchinson, R.J. Fox, E. Havrdova, N.C. Kurukulasuriya, S.P. Sarda, and S. Agarwal Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison Curr Med Res Opin 30 2014 613 627
133. + cells, and decreased macrophage IL-6 expression Int Immunopharmacol 9 2009 134 143
134. S. Jafarirad, F. Siassi, M.H. Harirchian, M.A. Sahraian, M.R. Eshraghian, and F. Shokri The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis J Neurosci Rural Pract 3 2012 294 298
135. V.A. Jagannath, Z. Fedorowicz, G.V. Asokan, E.W. Robak, and L. Whamond Vitamin D for the management of multiple sclerosis Cochrane Database Syst Rev 2010 CD008422
136. S.R. Jahromi, M. Toghae, M.J.R. Jahromi, and M. Aloosh Dietary pattern and risk of multiple sclerosis Iran J Neurol 11 2012 47 53
137. N. Jantaratnotai, P. Utaisincharoen, P. Sanvarinda, A. Thampithak, and Y. Sanvarinda Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia Int Immunopharmacol 17 2013 483 488
138. Y. Jia, J. Jing, Y. Bai, Z. Li, L. Liu, and J. Luo Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-kappaB signaling pathways PLoS One 6 2011 e27006
139. S. Jin, M. Park, and J.-H. Song (-)-Epigallocatechin-3-gallate inhibits voltage-gated proton currents in BV2 microglial cells Eur J Pharmacol 698 2013 154 160
140. S.K. Johnson, B.J. Diamond, S. Rausch, M. Kaufman, S.C. Shiflett, and L. Graves The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial Explore (NY) 2 2006 19 24
141. S. Joshi, L.C. Pantalena, X.K. Liu, S.L. Gaffen, H. Liu, and C. Rohowsky-Kochan 1,25-Dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A Mol Cell Biol 31 2011 3653 3669
142. S.I. Judge, and C.T. Bever Jr. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment Pharmacol Ther 111 2006 224 259
143. C. Kaltschmidt, B. Kaltschmidt, H. Neumann, H. Wekerle, and P.A. Baeuerle Constitutive NF-kappa B activity in neurons Mol Cell Biol 14 1994 3981 3992
144. M.T. Kampman, L.H. Steffensen, S.I. Mellgren, and L. Jorgensen Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial Mult Scler 18 2012 1144 1151
145. Q.-C. Kan, S.M. Zhang, Y.-M. Xu, G.-X. Zhang, and L. Zhu Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis Neurosci Lett 560 2014 92 97
146. Q.-C. Kan, L. Zhu, N. Liu, and G.-X. Zhang Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity Immunol Res 56 2013 189 196
147. S. Kanakasabai, C.C. Walline, S. Chakraborty, and J.J. Bright PPARdelta deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis Brain Res 1376 2011 101 112
148. L.D. Kandagaddala, M.J. Kang, B.C. Chung, T.A. Patterson, and O.S. Kwon Expression and activation of matrix metalloproteinase-9 and NADPH oxidase in tissues and plasma of experimental autoimmune encephalomyelitis in mice Exp Toxicol Pathol 64 2012 109 114
149. T. Kanekiyo, H. Xu, and G. Bu ApoE and Abeta in Alzheimer's disease: accidental encounters or partners? Neuron 81 2014 740 754
150. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol 5 2005 749 759
151. D. Karussis, D.M. Michaelson, N. Grigoriadis, A.D. Korezyn, R. Mizrachi-Koll, and S. Chapman Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis Mult Scler 9 2003 476 480
152. A.R. Kennedy The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent Am J Clin Nutr 68 1998 1406S 1412S
153. S.M. Kerfoot, M.U. Norman, B.M. Lapointe, C.S. Bonder, L. Zbytnuik, and P. Kubes Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis J Immunol 176 2006 6225 6234
154. + channel Acta Physiol (Oxf) 202 2011 185 192
155. C.Y. Kim, C. Lee, G.H. Park, and J.H. Jang Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity Arch Pharm Res 32 2009 869 881
156. M. Kleinewietfeld, A. Manzel, J. Titze, H. Kvakan, N. Yosef, and R.A. Linker Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells Nature 496 2013 518 522
157. C. Klemann, B.J. Raveney, A.K. Klemann, T. Ozawa, S. von Horsten, and K. Shudo Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis Am J Pathol 174 2009 2234 2245
158. J. Koehler, W. Feneberg, M. Meier, and W. Pollmann Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity Int J Neurosci 9 2014 652 656
159. M. Kohno, H. Hasegawa, A. Inoue, M. Muraoka, T. Miyazaki, and K. Oka Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18 Biochem Biophys Res Commun 347 2006 827 832
160. W. Kong, H. Li, R.F. Tuma, and D. Ganea Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS Cell Immunol 287 2014 1 17
161. W. Kong, J.-H. Yen, and D. Ganea Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis Brain Behav Immun 25 2011 872 882
162. E. Kozela, N. Lev, N. Kaushansky, R. Eilam, N. Rimmerman, and R. Levy Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice Br J Pharmacol 163 2011 1507 1519
163. V. Kraus, R. Srivastava, S.R. Kalluri, U. Seidel, M. Schuelke, and M. Schimmel Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease Neurology 82 2014 470 473
164. X. Kuang, Y. Huang, H.F. Gu, X.Y. Zu, W.Y. Zou, and Z.B. Song Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats Eur J Pharmacol 676 2012 51 56
165. I. Kubajewska, and C.S. Constantinescu Cannabinoids and experimental models of multiple sclerosis Immunobiology 215 2010 647 657
166. Y.T. Kuo, P.W. So, J.R. Parkinson, W.S. Yu, M. Hankir, and A.H. Herlihy The combined effects on neuronal activation and blood-brain barrier permeability of time and n - 3 polyunsaturated fatty acids in mice, as measured in vivo using MEMRI Neuroimage 50 2010 1384 1391
167. H.-K. Kwon, G.-C. Kim, Y. Kim, W. Hwang, A. Jash, and A. Sahoo Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response Clin Immunol 146 2013 217 227
168. + T cells by probiotics administration suppresses immune disorders Proc Natl Acad Sci U S A 107 2010 2159 2164
169. A.C. La Flamme, K. Ruddenklau, and B.T. Bäckström Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis Infect Immun 71 2003 4996 5004
170. R.M. Langford, J. Mares, A. Novotna, M. Vachova, I. Novakova, and W. Notcutt A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis J Neurol 260 2013 984 997
171. H. Lassmann, and J. van Horssen The molecular basis of neurodegeneration in multiple sclerosis FEBS Lett 585 2011 3715 3723
172. I. Lauritzen, N. Blondeau, C. Heurteaux, C. Widmann, G. Romey, and M. Lazdunski Polyunsaturated fatty acids are potent neuroprotectors EMBO J 19 2000 1784 1793
173. C. Lebrun, H. Alchaar, M. Candito, V. Bourg, and M. Chatel Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue Mult Scler 12 2006 321 324
174. H. Lee, Y.O. Kim, H. Kim, S.Y. Kim, H.S. Noh, and S.S. Kang Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia FASEB J 17 2003 1943 1944
175. Y.K. Lee, J.S. Menezes, Y. Umesaki, and S.K. Mazmanian Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis Proc Natl Acad Sci U S A 108 Suppl. 1 2011 4615 4622
176. J.M. Lemire, and D.C. Archer 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis J Clin Invest 87 1991 1103 1107
177. L.I. Levin, K.L. Munger, E.J. O'Reilly, K.I. Falk, and A. Ascherio Primary infection with the Epstein-Barr virus and risk of multiple sclerosis Ann Neurol 67 2010 824 830
178. B. Li, D.J. Baylink, C. Deb, C. Zannetti, F. Rajaallah, and W. Xing 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo PLoS One 8 2013 e58808
179. B. Li, W. Cui, J. Liu, R. Li, Q. Liu, and X.H. Xie Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice Exp Neurol 250 2013 239 249
180. F.Q. Li, G.D. Sempowski, S.E. McKenna, D.T. Laskowitz, C.A. Colton, and M.P. Vitek Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis J Pharmacol Exp Ther 318 2006 956 965
181. S. Li, A.C. Vana, R. Ribeiro, and Y. Zhang Distinct role of nitric oxide and peroxynitrite in mediating oligodendrocyte toxicity in culture and in experimental autoimmune encephalomyelitis Neuroscience 184 2011 107 119
182. X.Q. Li, J. Wang, B. Fang, W.F. Tan, and H. Ma Intrathecal antagonism of microglial TLR4 reduces inflammatory damage to blood-spinal cord barrier following ischemia/reperfusion injury in rats Mol Brain 7 2014 28
183. Q. Li, J. Xia, Y. Yao, D.W. Gong, H. Shi, and Q. Zhou Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells Breast Cancer Res Treat 141 2013 317 324
184. C. Li, X. Yang, J. He, J.E. Hixson, D. Gu, and D.C. Rao A gene-based analysis of variants in the serum/glucocorticoid regulated kinase (SGK) genes with blood pressure responses to sodium intake: the GenSalt Study PLoS One 9 2014 e98432
185. Y.T. Lian, X.F. Yang, Z.H. Wang, Y. Yang, Y. Yang, and Y.W. Shu Curcumin serves as a human kv1.3 blocker to inhibit effector memory T lymphocyte activities Phytother Res 27 2013 1321 1327
186. C.M. Lill, T. Liu, B.M. Schjeide, J.T. Roehr, D.A. Akkad, and V. Damotte Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects J Med Genet 49 2012 558 562
187. R.A. Linker, D.H. Lee, S. Ryan, A.M. van Dam, R. Conrad, and P. Bista Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway Brain 134 2011 678 692
188. J. Liu, R. Cinar, K. Xiong, G. Godlewski, T. Jourdan, and Y. Lin Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase Proc Natl Acad Sci U S A 110 2013 18832 18837
189. H. Liu, S.J. Danthi, and J.J. Enyeart Curcumin potently blocks Kv1.4 potassium channels Biochem Biophys Res Commun 344 2006 1161 1165
190. Y. Liu, A.T. Holdbrooks, P. Sarno, A.L. Rowse, L.L. Yanagisawa, and B.C. McFarland Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis J Immunol 192 2014 59 72
191. + T cells prevents development of experimental autoimmune diseases J Immunol 180 2008 6070 6076
192. J.Z. Long, W. Li, L. Booker, J.J. Burston, S.G. Kinsey, and J.E. Schlosburg Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Nat Chem Biol 5 2009 37 44
193. W.D. Lyman, J.R. Sonett, C.F. Brosnan, R. Elkin, and M.B. Bornstein Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis J Neuroimmunol 23 1989 73 81
194. A.J. Macpherson, and N.L. Harris Interactions between commensal intestinal bacteria and the immune system Nat Rev Immunol 4 2004 478 485
195. B.D. Mahon, S.A. Gordon, J. Cruz, F. Cosman, and M.T. Cantorna Cytokine profile in patients with multiple sclerosis following vitamin D supplementation J Neuroimmunol 134 2003 128 132
196. W. Maier, M. Bednorz, S. Meister, A. Roebroek, S. Weggen, and U. Schmitt LRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype Mol Neurodegener 8 2013 25
197. C.E. Markowitz, S. Spitsin, V. Zimmerman, D. Jacobs, J.K. Udupa, and D.C. Hooper The treatment of multiple sclerosis with inosine J Altern Complement Med 15 2009 619 625
198. M. Marta Toll-like receptors in multiple sclerosis mouse experimental models Ann N Y Acad Sci 1173 2009 458 462
199. B.R. Martin Cellular effects of cannabinoids Pharmacol Rev 38 1986 45 74
200. M.F. Martin-Eauclaire, and P.E. Bougis Potassium channels blockers from the venom of Androctonus mauretanicus mauretanicus J Toxicol 2012 2012 103608
201. P. May, H.H. Bock, and J.R. Nofer Low density receptor-related protein 1 (LRP1) promotes anti-inflammatory phenotype in murine macrophages Cell Tissue Res 354 2013 887 889
202. C.G. Mayne, J.A. Spanier, L.M. Relland, C.B. Williams, and C.E. Hayes 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis Eur J Immunol 41 2011 822 832
203. P.L. McCormack Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis Drugs 73 2013 1463 1481
204. D. McHugh GPR18 in microglia: implications for the CNS and endocannabinoid system signalling Br J Pharmacol 167 2012 1575 1582
205. J.M. McMahon, S. McQuaid, R. Reynolds, and U.F. FitzGerald Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis Mult Scler 18 2012 1437 1447
206. M. Mecha, A. Feliu, P.M. Inigo, L. Mestre, F.J. Carrillo-Salinas, and C. Guaza Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors Neurobiol Dis 59 2013 141 150
207. 3 to suppress experimental autoimmune encephalomyelitis in mice Arch Biochem Biophys 408 2002 200 204
208. S. Mehri, M.A. Meshki, and H. Hosseinzadeh Linalool as a neuroprotective agent against acrylamide-induced neurotoxicity in Wistar rats Drug Chem Toxicol 21 2014 1 5
209. B.K. Mehta New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence J Neurol Sci 292 2010 5 10
210. N. Melzer, and S.G. Meuth Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies Clin Exp Immunol 175 2014 359 372
211. D.M. Menichella, M. Majdan, R. Awatramani, D.A. Goodenough, E. Sirkowski, and S.S. Scherer Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity J Neurosci 26 2006 10984 10991
212. + channel 1 (TASK1) and TASK3 critically influence T lymphocyte effector functions J Biol Chem 283 2008 14559 14570
213. D. Miljković, D. Dekanski, Z. Miljković, M. Momcilović, and M. Mostarica-Stojkovic Dry olive leaf extract ameliorates experimental autoimmune encephalomyelitis Clin Nutr 28 2009 346 350
214. + regulatory T cells Biochem Biophys Res Commun 402 2010 209 215
215. M. Miyake, K. Sasaki, K. Ide, Y. Matsukura, K. Shijima, and D. Fujiwara Highly oligomeric procyanidins ameliorate experimental autoimmune encephalomyelitis via suppression of Th1 immunity J Immunol 176 2006 5797 5804
216. F.M. Mo, L. Offertaler, and G. Kunos Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1 Eur J Pharmacol 489 2004 21 27
217. D.C. Mohr, S.L. Hart, L. Julian, D. Cox, and D. Pelletier Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis BMJ 328 2004 731
218. V. Moline-Velazquez, M.C. Ortega, V. Vila Del Sol, C. Melero-Jerez, F. de Castro, and D. Clemente The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability Neurobiol Dis 67 2014 149 164
219. D.O. Moon, Y.-H. Choi, N.-D. Kim, Y.-M. Park, and G.Y. Kim Anti-inflammatory effects of beta-lapachone in lipopolysaccharide-stimulated BV2 microglia Int Immunopharmacol 7 2007 506 514
220. M. Moriya, Y. Nakatsuji, T. Okuno, T. Hamasaki, M. Sawada, and S. Sakoda Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats J Neuroimmunol 170 2005 11 20
221. G. Mosayebi, A. Ghazavi, K. Ghasami, Y. Jand, and P. Kokhaei Therapeutic effect of vitamin D3 in multiple sclerosis patients Immunol Invest 40 2011 627 639
222. E.M. Mowry, L.B. Krupp, M. Milazzo, D. Chabas, J.B. Strober, and A.L. Belman Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis Ann Neurol 67 2010 618 624
223. P.S. Mueller, M.W. Kies, E.C. Alvord Jr., and C.M. Shaw Prevention of experimental allergic encephalomyelitis (EAE) by vitamin C deprivation J Exp Med 115 1962 329 338
224. S. Muller, T. Quast, A. Schroder, S. Hucke, L. Klotz, and J. Jantsch Salt-dependent chemotaxis of macrophages PLoS One 8 2013 e73439
225. K.L. Munger, and A. Ascherio Prevention and treatment of MS: studying the effects of vitamin D Mult Scler 17 2011 1405 1411
226. K.L. Munger, T. Chitnis, and A. Ascherio Body size and risk of MS in two cohorts of US women Neurology 73 2009 1543 1550
227. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2006 2832 2838
228. T. Murase, K. Misawa, S. Haramizu, and T. Hase Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway Biochem Pharmacol 78 2009 78 84
229. G. Musumeci, G. Grasselli, S. Rossi, V. De Chiara, A. Musella, and C. Motta Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-alpha and of IL-1beta in experimental autoimmune encephalomyelitis Neurobiol Dis 43 2011 669 677
230. G. Muthian, and J.J. Bright Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte J Clin Immunol 24 2004 542 552
231. M.P. Mycko, R. Papoian, U. Boschert, C.S. Raine, and K.W. Selmaj cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity Brain 126 2003 1048 1057
232. H.K. Na, and Y.J. Surh Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG Food Chem Toxicol 46 2008 1271 1278
233. C. Nakajima, A. Kulik, M. Frotscher, J. Herz, M. Schafer, and H.H. Bock Low density lipoprotein receptor-related protein 1 (LRP1) modulates N-methyl-d-aspartate (NMDA) receptor-dependent intracellular signaling and NMDA-induced regulation of postsynaptic protein complexes J Biol Chem 288 2013 21909 21923
234. A. Nakamura, S. Fujiwara, I. Matsumoto, and K. Abe Stress repression in restrained rats by (R)-(-)-linalool inhalation and gene expression profiling of their whole blood cells J Agric Food Chem 57 2009 5480 5485
235. S. Nataf, E. Garcion, F. Darcy, D. Chabannes, J.Y. Muller, and P. Brachet 1,25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis J Neuropathol Exp Neurol 55 1996 904 914
236. C. Natarajan, and J.J. Bright Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes J Immunol 168 2002 6506 6513
237. I. Neveu, P. Naveilhan, C. Menaa, D. Wion, P. Brachet, and M. Garabedian Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro J Neurosci Res 38 1994 214 220
238. X. Ni, E.B. Geller, M.J. Eppihimer, T.K. Eisenstein, M.W. Adler, and R.F. Tuma Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model Mult Scler 10 2004 158 164
239. S. Nicolussi, J.M. Viveros-Paredes, M.S. Gachet, M. Rau, M.E. Flores-Soto, and M. Blunder Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice Pharmacol Res 80 2014 52 65
240. I. Nikic, D. Merkler, C. Sorbara, M. Brinkoetter, M. Kreutzfeldt, and F.M. Bareyre A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis Nat Med 17 2011 495 499
241. R. Nosá̘, K. Drábiková, V. Jančinová, T. Perečko, G. Ambrožová, and M. Cíž On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes Oxid Med Cell Longev 2014 2014 706269
242. J. Ochoa-Repáraz, D.W. Mielcarz, L.E. Ditrio, A.R. Burroughs, D.M. Foureau, and S. Haque-Begum Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis J Immunol 183 2009 6041 6050
243. D. Ontaneda, M. Hyland, and J.A. Cohen Multiple sclerosis: new insights in pathogenesis and novel therapeutics Annu Rev Med 63 2012 389 404
244. S.K. Orr, and R.P. Bazinet The emerging role of docosahexaenoic acid in neuroinflammation Curr Opin Investig Drugs 9 2008 735 743
245. H.A. Overton, A.J. Babbs, S.M. Doel, M.C. Fyfe, L.S. Gardner, and G. Griffin Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents Cell Metab 3 2006 167 175
246. H.L. Pahl Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 18 1999 6853 6866
247. J. Palazuelos, N. Davoust, B. Julien, E. Hatterer, T. Aguado, and R. Mechoulam The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis J Biol Chem 283 2008 13320 13329
248. M.W. Pennington, C. Beeton, C.A. Galea, B.J. Smith, V. Chi, and K.P. Monaghan Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes Mol Pharmacol 75 2009 762 773
249. R.G. Pertwee Pharmacology of cannabinoid CB1 and CB2 receptors Pharmacol Ther 74 1997 129 180
250. R.G. Pertwee Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities Philos Trans R Soc Lond B Biol Sci 367 2012 3353 3363
251. N. Plesnila, L. von Baumgarten, M. Retiounskaia, D. Engel, A. Ardeshiri, and R. Zimmermann Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-kappaB transcriptional activity Cell Death Differ 14 2007 1529 1541
252. C. Politi, D. Del Turco, J.M. Sie, P.A. Golinski, I. Tegeder, and T. Deller Accumulation of phosphorylated I kappaB alpha and activated IKK in nodes of Ranvier Neuropathol Appl Neurobiol 34 2008 357 365
253. B. Pollinger, G. Krishnamoorthy, K. Berer, H. Lassmann, M.R. Bosl, and R. Dunn Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells J Exp Med 206 2009 1303 1316
254. G.M. Portela-Gomes, M. Stridsberg, L. Grimelius, U.G. Falkmer, and S. Falkmer Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies APMIS 112 2004 663 673
255. B. Prietl, S. Pilz, M. Wolf, A. Tomaschitz, B. Obermayer-Pietsch, and W. Graninger Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J 12 2010 136 139
256. M. Prinz, F. Garbe, H. Schmidt, A. Mildner, I. Gutcher, and K. Wolter Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis J Clin Invest 116 2006 456 464
257. G. Pryce, Z. Ahmed, D.J. Hankey, S.J. Jackson, J.L. Croxford, and J.M. Pocock Cannabinoids inhibit neurodegeneration in models of multiple sclerosis Brain 126 2003 2191 2202
258. M.K. Racke, D. Burnett, S.H. Pak, P.S. Albert, B. Cannella, and C.S. Raine Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course J Immunol 154 1995 450 458
259. R. Ramesh, L. Kozhaya, K. McKevitt, I.M. Djuretic, T.J. Carlson, and M.A. Quintero Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids J Exp Med 211 2014 89 104
260. V. Ramirez-Ramirez, M.A. Macias-Islas, G.G. Ortiz, F. Pacheco-Moises, E.D. Torres-Sanchez, and T.E. Sorto-Gomez Efficacy of fish oil on serum of TNF α, IL-1 β, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b Oxid Med Cell Longev 2013 2013 709493
261. S. Razeghi Jahromi, S.R. Arrefhosseini, A. Ghaemi, A. Alizadeh, H. Moradi Tabriz, and M. Togha Alleviation of experimental allergic encephalomyelitis in C57BL/6 mice by soy daidzein Iran J Allergy Asthma Immunol 13 2014 256 264
262. Y. Ren, L. Lu, T.B. Guo, J. Qiu, Y. Yang, and A. Liu Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-gamma in experimental autoimmune encephalomyelitis J Immunol 181 2008 1491 1498
263. M. Reto, M.E. Figueira, H.M. Filipe, and C.M.M. Almeida Chemical composition of green tea (Camellia sinensis) infusions commercialized in Portugal Plant Foods Hum Nutr 62 2007 139 144
264. T. Riise, M.W. Nortvedt, and A. Ascherio Smoking is a risk factor for multiple sclerosis Neurology 61 2003 1122 1124
265. H.M. Roche, A.M. Terres, I.B. Black, M.J. Gibney, and D. Kelleher Fatty acids and epithelial permeability: effect of conjugated linoleic acid in Caco-2 cells Gut 48 2001 797 802
266. D.J. Rog, T.J. Nurmikko, and C.A. Young Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial Clin Ther 29 2007 2068 2079
267. L. Romeo, M. Intrieri, V. D'Agata, N.G. Mangano, G. Oriani, and M.L. Ontario The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress J Am Coll Nutr 28 2009 492S 499S (Suppl.)
268. B. Rosche, K.-D. Wernecke, S. Ohlraun, J.-M. Dörr, and F. Paul Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial Trials 14 2013 112
269. E. Rosjo, K.M. Myhr, K.I. Loken-Amsrud, S.J. Bakke, A.G. Beiske, and K.S. Bjerve Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis J Neuroimmunol 271 2014 60 65
270. B.D. Roussel, A.J. Kruppa, E. Miranda, D.C. Crowther, D.A. Lomas, and S.J. Marciniak Endoplasmic reticulum dysfunction in neurological disease Lancet Neurol 12 2013 105 118
271. W. Royal III, S. Gartner, and C.D. Gajewski Retinol measurements and retinoid receptor gene expression in patients with multiple sclerosis Mult Scler 8 2002 452 458
272. M. Ruggieri, C. Avolio, P. Livrea, and M. Trojano Glatiramer acetate in multiple sclerosis: a review CNS Drug Rev 13 2007 178 191
273. T.F. Runia, W.C.J. Hop, Y.B. de Rijke, D. Buljevac, and R.Q. Hintzen Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis Neurology 79 2012 261 266
274. R. Russell, I. Gori, C. Pellegrini, R. Kumar, C. Achtari, and G.O. Canny Lipoxin A4 is a novel estrogen receptor modulator FASEB J 25 2011 4326 4337
275. S. Salvati, A. Di Biase, L. Attorri, R. Di Benedetto, M. Sanchez, and L. Lorenzini Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats J Nutr Biochem 24 2013 1645 1654
276. A.J. Sanchez, and A. Garcia-Merino Neuroprotective agents: cannabinoids Clin Immunol 142 2012 57 67
277. M. Sanoobar, S. Eghtesadi, A. Azimi, M. Khalili, S. Jazayeri, and M. Reza Gohari Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis Int J Neurosci 123 2013 776 782
278. + regulatory T cells Life Sci 91 2012 1263 1269
279. J. Sastre-Garriga, C. Vila, S. Clissold, and X. Montalban THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis Expert Rev Neurother 11 2011 627 637
280. F. Sato, N.E. Martinez, M. Shahid, J.W. Rose, N.G. Carlson, and I. Tsunoda Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis Am J Pathol 183 2013 1390 1396
281. G. Scapagnini, S. Vasto, N.G. Abraham, C. Caruso, D. Zella, and G. Fabio Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders Mol Neurobiol 44 2011 192 201
282. C.M. Schaldach, J. Riby, and L.F. Bjeldanes Lipoxin A4: a new class of ligand for the Ah receptor Biochemistry 38 1999 7594 7600
283. L. Schirmer, R. Srivastava, S.R. Kalluri, S. Bottinger, M. Herwerth, and D. Carassiti Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions Ann Neurol 6 2014 810 826
284. J.E. Schlosburg, J.L. Blankman, J.Z. Long, D.K. Nomura, B. Pan, and S.G. Kinsey Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system Nat Neurosci 13 2010 1113 1119
285. C. Schultz, H.G. Konig, D. Del Turco, C. Politi, G.P. Eckert, and E. Ghebremedhin Coincident enrichment of phosphorylated IkappaBalpha, activated IKK, and phosphorylated p65 in the axon initial segment of neurons Mol Cell Neurosci 33 2006 68 80
286. J.M. Schwab, N. Chiang, M. Arita, and C.N. Serhan Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 2007 869 874
287. F.J. Schweigert Inflammation-induced changes in the nutritional biomarkers serum retinol and carotenoids Curr Opin Clin Nutr Metab Care 4 2001 477 481
288. S.R. Schwid, M.D. Petrie, M.P. McDermott, D.S. Tierney, D.H. Mason, and A.D. Goodman Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis Neurology 48 1997 817 821
289. S. Sedehizadeh, M. Keogh, and P. Maddison The use of aminopyridines in neurological disorders Clin Neuropharmacol 35 2012 191 200
290. C.N. Serhan, G. Fredman, R. Yang, S. Karamnov, L.S. Belayev, and N.G. Bazan Novel proresolving aspirin-triggered DHA pathway Chem Biol 18 2011 976 987
291. C.N. Serhan, K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, and T. Baer Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes J Immunol 176 2006 1848 1859
292. C.N. Serhan, U. Hirsch, J. Palmblad, and B. Samuelsson Formation of lipoxin A by granulocytes from eosinophilic donors FEBS Lett 217 1987 242 246
293. C.N. Serhan, R. Yang, K. Martinod, K. Kasuga, P.S. Pillai, and T.F. Porter Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions J Exp Med 206 2009 15 23
294. M.G. Serpell, W. Notcutt, and C. Collin Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis J Neurol 260 2013 285 295
295. + channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation Br J Pharmacol 165 2012 1467 1475
296. O.F. Sharifov, G. Nayyar, D.W. Garber, S.P. Handattu, V.K. Mishra, and D. Goldberg Apolipoprotein E mimetics and cholesterol-lowering properties Am J Cardiovasc Drugs 11 2011 371 381
297. C.C. Shieh, M. Coghlan, J.P. Sullivan, and M. Gopalakrishnan Potassium channels: molecular defects, diseases, and therapeutic opportunities Pharmacol Rev 52 2000 557 594
298. S. Shin, K.A. Walz, A.S. Archambault, J. Sim, B.P. Bollman, and J. Koenigsknecht-Talboo Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis J Neuroimmunol 271 2014 8 17
299. N.L. Sicotte, S.M. Liva, R. Klutch, P. Pfeiffer, S. Bouvier, and S. Odesa Treatment of multiple sclerosis with the pregnancy hormone estriol Ann Neurol 52 2002 421 428
300. S.B. Simmons, E.R. Pierson, S.Y. Lee, and J.M. Goverman Modeling the heterogeneity of multiple sclerosis in animals Trends Immunol 34 2013 410 422
301. S. Simpson, B. Taylor, L. Blizzard, A.-L. Ponsonby, F. Pittas, and H. Tremlett Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis Ann Neurol 68 2010 193 203
302. N.P. Singh, V.L. Hegde, L.J. Hofseth, M. Nagarkatti, and P. Nagarkatti Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor Mol Pharmacol 72 2007 1508 1521
303. S. Sisay, G. Pryce, S.J. Jackson, C. Tanner, R.A. Ross, and G.J. Michael Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis PLoS One 8 2013 e76907
304. H.H. Smits, A. Engering, D. van der Kleij, E.C. de Jong, K. Schipper, and T.M.M. van Capel Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin J Allergy Clin Immunol 115 2005 1260 1267
305. J. Smolders, R. Hupperts, F. Barkhof, L.M. Grimaldi, T. Holmoy, and J. Killestein Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial J Neurol Sci 311 2011 44 49
306. J. Smolders, K.G. Schuurman, M.E. van Strien, J. Melief, D. Hendrickx, and E.M. Hol Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue J Neuropathol Exp Neurol 72 2013 91 105
307. J.-S. So, M.-K. Song, H.-K. Kwon, C.-G. Lee, C.S. Chae, and A. Sahoo Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis Life Sci 88 2011 358 366
308. M. Soilu-Hanninen, L. Airas, I. Mononen, A. Heikkila, M. Viljanen, and A. Hanninen 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis Mult Scler 11 2005 266 271
309. K.M. Spach, and C.E. Hayes Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice J Immunol 175 2005 4119 4126
310. S.V. Spitsin, G.S. Scott, T. Mikheeva, A. Zborek, R.B. Kean, and C.M. Brimer Comparison of uric acid and ascorbic acid in protection against EAE Free Radic Biol Med 33 2002 1363 1371
311. R. Srivastava, M. Aslam, S.R. Kalluri, L. Schirmer, D. Buck, and B. Tackenberg Potassium channel KIR4.1 as an immune target in multiple sclerosis N Engl J Med 367 2012 115 123
312. J. Staples, A.L. Ponsonby, and L. Lim Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis BMJ 340 2010 c1640
313. M.S. Stein, Y. Liu, O.M. Gray, J.E. Baker, S.C. Kolbe, and M.R. Ditchfield A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis Neurology 77 2011 1611 1618
314. D. Stoye, C. Schubert, A. Goihl, K. Guttek, A. Reinhold, and S. Brocke Zinc aspartate suppresses T cell activation in vitro and relapsing experimental autoimmune encephalomyelitis in SJL/J mice Biometals 25 2012 529 539
315. R.W. Summers, D.E. Elliott, K. Qadir, J.F. Urban, R. Thompson, and J.V. Weinstock Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease Am J Gastroenterol 98 2003 2034 2041
316. Q. Sun, Y. Zheng, X. Zhang, X. Hu, Y. Wang, and S. Zhang Novel immunoregulatory properties of EGCG on reducing inflammation in EAE Front Biosci (Landmark Ed) 18 2013 332 342
317. E.J. Tarcha, V. Chi, E.J. Munoz-Elias, D. Bailey, L.M. Londono, and S.K. Upadhyay Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease J Pharmacol Exp Ther 342 2012 642 653
318. M. Thorne, C.S. Moore, and G.S. Robertson Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: effects of darbepoetin alfa on TIMP-1 null and wild-type mice J Neuroimmunol 211 2009 92 100
319. O. Torkildsen, K.I. Loken-Amsrud, S. Wergeland, K.M. Myhr, and T. Holmoy Fat-soluble vitamins as disease modulators in multiple sclerosis Acta Neurol Scand Suppl 196 2013 16 23
320. O. Torkildsen, S. Wergeland, S.J. Bakke, A.G. Beiske, K.S. Bjerve, and H. Hovdal Omega-3 fatty acid treatment in multiple sclerosis (OFAMS study): a randomized, double-blind, placebo-controlled trial Arch Neurol 69 2012 1044 1051
321. T. Touil, B. Ciric, E. Ventura, K.S. Shindler, B. Gran, and A. Rostami Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis J Neurol Sci 271 2008 191 202
322. M.G. Traber Vitamin E, nuclear receptors and xenobiotic metabolism Arch Biochem Biophys 423 2004 6 11
323. P.Y. Tsai, S.M. Ka, J.M. Chang, H.C. Chen, H.A. Shui, and C.Y. Li Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation Free Radic Biol Med 51 2011 744 754
324. N. Ueno, M. Fujiya, S. Segawa, T. Nata, K. Moriichi, and H. Tanabe Heat-killed body of Lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function Inflamm Bowel Dis 17 2011 2235 2250
325. K. Unoda, Y. Doi, H. Nakajima, K. Yamane, T. Hosokawa, and S. Ishida Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis J Neuroimmunol 256 2013 7 12
326. P. van den Elzen, S. Garg, L. Leon, M. Brigl, E.A. Leadbetter, and J.E. Gumperz Apolipoprotein-mediated pathways of lipid antigen presentation Nature 437 2005 906 910
327. I.A. van der Mei, A.L. Ponsonby, L. Blizzard, and T. Dwyer Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation Neuroepidemiology 20 2001 168 174
328. B.W. van Oosten, F. Barkhof, L. Truyen, J.B. Boringa, F.W. Bertelsmann, and B.M. von Blomberg Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 Neurology 47 1996 1531 1534
329. E.L. Veale, R. Buswell, C.E. Clarke, and A. Mathie Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandamide Br J Pharmacol 152 2007 778 786
330. G. von Geldern, and E.M. Mowry The influence of nutritional factors on the prognosis of multiple sclerosis Nat Rev Neurol 8 2012 678 689
331. M. Vrethem, E. Mattsson, H. Hebelka, K. Leerbeck, A. Osterberg, and A.M. Landtblom Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid Mult Scler 9 2003 239 245
332. D.T. Wade, C. Collin, C. Stott, and P. Duncombe Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis Mult Scler 16 2010 707 714
333. D.T. Wade, P.M. Makela, H. House, C. Bateman, and P. Robson Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis Mult Scler 12 2006 639 645
334. D.T. Wade, C.A. Young, K.R. Chaudhuri, and D.L.W. Davidson A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and l-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis J Neurol Neurosurg Psychiatry 73 2002 246 249
335. H. Waldner, M. Collins, and V.K. Kuchroo Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease J Clin Invest 113 2004 990 997
336. + channels in terminal and juxtaparanodal regions of neurons Nature 365 1993 75 79
337. M. Webb, L. Luo, J.Y. Ma, and C.S. Tham Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis Neurosci Lett 439 2008 106 110
338. J. Wei, M. Zheng, P. Liang, Y. Wei, X. Yin, and Y. Tang Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis Neurobiol Dis 56 2013 59 65
339. B. Weinstock-Guttman, M. Baier, Y. Park, J. Feichter, P. Lee-Kwen, and E. Gallagher Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients Prostaglandins Leukot Essent Fatty Acids 73 2005 397 404
340. S. Wergeland, O. Torkildsen, L. Bo, and K.-M. Myhr Polyunsaturated fatty acids in multiple sclerosis therapy Acta Neurol Scand Suppl 2012 70 75
341. K.H. Weylandt, C.Y. Chiu, B. Gomolka, S.F. Waechter, and B. Wiedenmann Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation Prostaglandins Other Lipid Mediat 97 2012 73 82
342. J.H. White Vitamin D metabolism and signaling in the immune system J Biol Chem 13 2012 21 29
343. D.M. Wingerchuk, J. Lesaux, G.P.A. Rice, M. Kremenchutzky, and G.C. Ebers A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis J Neurol Neurosurg Psychiatry 76 2005 1294 1296
344. M.E. Witte, D.J. Mahad, H. Lassmann, and J. van Horssen Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis Trends Mol Med 20 2014 179 187
345. C.W. Wong, W.K. Seow, and Y.H. Thong Comparative effects of tetrandrine and berbamine on acute and relapsing experimental allergic encephalitis in Lewis rats Int Arch Allergy Immunol 97 1992 31 36
346. H. Wu, C.J. Kelley, A. Pino-Figueroa, H.D. Vu, and T.J. Maher Macamides and their synthetic analogs: evaluation of in vitro FAAH inhibition Bioorg Med Chem 21 2013 5188 5197
347. L. Xie, X.-K. Li, N. Funeshima-Fuji, H. Kimura, Y. Matsumoto, and Y. Isaka Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production Int Immunopharmacol 9 2009 575 581
348. J. Xin, D.L. Feinstein, M.J. Hejna, S.A. Lorens, and S.O. McGuire Beneficial effects of blueberries in experimental autoimmune encephalomyelitis J Agric Food Chem 60 2012 5743 5748
349. J. Xu, G. Wagoner, J.C. Douglas, and P.D. Drew β-Lapachone ameliorization of experimental autoimmune encephalomyelitis J Neuroimmunol 254 2013 46 54
350. J. Xu, Y. Zhang, Y. Xiao, S. Ma, Q. Liu, and S. Dang Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARbeta/delta: a potential therapeutic role for CNS autoimmune disease Cell Death Dis 4 2013 e569
351. V. Yadav, G. Marracci, J. Lovera, W. Woodward, K. Bogardus, and W. Marquardt Lipoic acid in multiple sclerosis: a pilot study Mult Scler 11 2005 159 165
352. K. Yamagata, M. Tagami, F. Takenaga, Y. Yamori, Y. Nara, and S. Itoh Polyunsaturated fatty acids induce tight junctions to form in brain capillary endothelial cells Neuroscience 116 2003 649 656
353. J. Yan, and J.M. Greer NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis CNS Neurol Disord Drug Targets 7 2008 536 557
354. Q.-Q. Yin, C.-X. Liu, Y.-L. Wu, S.-F. Wu, Y. Wang, and X. Zhang Preventive and therapeutic effects of adenanthin on experimental autoimmune encephalomyelitis by inhibiting NF-κB signaling J Immunol 191 2013 2115 2125
355. H. Yoshino, K. Takahashi, S. Monzen, and I. Kashiwakura Effects of proteoglycan extracted from nasal cartilage of salmon heads on maturation of dendritic cells derived from human peripheral blood monocytes Biol Pharm Bull 33 2010 311 315
356. E.S. Yu, H.J. Min, S.Y. An, H.Y. Won, J.H. Hong, and E.S. Hwang Regulatory mechanisms of IL-2 and IFNgamma suppression by quercetin in T helper cells Biochem Pharmacol 76 2008 70 78
357. J.T. Yu, L. Tan, and J. Hardy Apolipoprotein E in Alzheimer's disease: an update Annu Rev Neurosci 37 2014 79 100
358. J.P. Zajicek, J.C. Hobart, A. Slade, D. Barnes, and P.G. Mattison Multiple sclerosis and extract of cannabis: results of the MUSEC trial J Neurol Neurosurg Psychiatry 83 2012 1125 1132
359. X.X. Zhan, Y. Liu, J.F. Yang, G.Y. Wang, L. Mu, and T.S. Zhang All-trans-retinoic acid ameliorates experimental allergic encephalomyelitis by affecting dendritic cell and monocyte development Immunology 138 2013 333 345
360. S. Zhang, Q. Kan, Y. Xu, G.-X. Zhang, and L. Zhu Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis Mediators Inflamm 2013 2013 736085
361. Y.K. Zhang, J.T. Liu, Z.W. Peng, H. Fan, A.H. Yao, and P. Cheng Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury J Neuroinflammation 10 2013 112
362. M. Zheng, J. Wei, Y. Tang, C. Yang, Y. Wei, and X. Yin ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9 J Mol Neurosci 2 2014 282 290
363. X. Zheng, S. Zhu, S. Chang, Y. Cao, J. Dong, and J. Li Protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats: role of NF-kappa B signaling Eur J Pharmacol 720 2013 147 157
364. B. Zou, D.P. Flaherty, D.S. Simpson, B.E. Maki, M.R. Miller, and J. Shi ML365: Development of Bis-Amides as Selective Inhibitors of the KCNK3/TASK1 Two Pore Potassium Channel 2013
365. A.W. Zuardi Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action Rev Bras Psiquiatr 30 2008 271 280
366. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sorgard, and V. Di Marzo Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457